Improved post-transplant outcomes in recent years for AML patients with FLT3-ITD and wild-type NPM1: a report from the EBMT acute leukemia working party

Purpose:Allogeneic hematopoietic cell transplantation (allo-HCT) is recommended in first complete remission (CR1) in patients with acute myeloid leukemia (AML) harboring FMS-like tyrosine kinase 3–internal tandem duplication (FLT3-ITD). We assessed changes over time in transplant characteristics and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical cancer research 2023-08
Hauptverfasser:	Bazarbachi, Ali, Labopin, Myriam, Gedde-Dahl, Tobias, Remenyi, Peter, Forcade, Edouard, Kröger, Nicolaus, Socié, Gerard, Craddock, Charles, Bourhis, Jean Henri, Versluis, Jurjen, Yakoub-Agha, Ibrahim, Salmenniemi, Urpu, El-Cheikh, Jean, Bug, Gesine, Esteve, Jordi, Nagler, Arnon, Ciceri, Fabio, Mohty, Mohamad
Format:	Artikel
Sprache:	eng
Schlagworte:	Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!